2020 American Transplant Congress Archives - Page 221 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

4:27pm-4:39pm: The Efficacy of Spheroidal Hepatocyte in Hepatocyte Transplantation

K. Shibuya, M. Watanabe, R. Kanazawa, Y. Ganchiku, R. Goto, A. Taketomi

Islet/Cell Transplantation • Virtual

4:27pm-4:39pm: The Impact of a Positive Crossmatch on KAS Patients and Organs

J. Lee¹, K. Sjöholm², C. Kjellman², T. Lorant², L. Winstedt², V. Nigro², K. M. Roupé², Å. Schiött², A. Runstrom², S. Taranto³, T. Baker³, D. Stewart³

Kidney Deceased Donor Allocation II • Virtual

4:27pm-4:39pm: The Impact Of Weight Reduction Surgery And Morbid Obesity On Renal Function After Transplantation

S. Negi¹, N. Saberi¹, P. Bouchard², a. Andalib², M. Cantarovich¹, S. Paraskevas¹, J. Tchervenkov¹

Kidney: Cardiovascular and Metabolic Complications II • Virtual

4:27pm-4:39pm: The Liver Protects All? Donor Specific Antibody Formation in Heart-Liver Transplant Recipients

A. W. Rogers¹, T. N. Eagar², C. Pham¹, J. Krisl¹, B. J. Pierce¹, M. Moaddab¹, R. Ghobrial³, B. Trachtenberg⁴, A. Bhimaraj⁴, A. O. Gaber³

Heart Transplantation: Antibodies and More • Virtual

4:27pm-4:39pm: The Perioperative Coagulation Profile of Hepatocellular Carcinoma During Liver Transplantation Compared to Patients with Non-Malignant Disease: A Cause or Association for Decreased Blood Product Utilization During Liver Transplantation?

H. B. Moore, E. Pomfret, J. Pomposelli, C. Walker, R. Choudhury, H. Yaffe, M. Wachs, T. Bak, K. Conzen, M. Adams, T. Pshak, T. L. Nydam

Liver: Hepatocellular Carcinoma and Other Malignancies II • Virtual

4:27pm-4:39pm: The Role of the Molecular Microscope to Guide Therapy for T-Cell Mediated Rejection in Kidney Transplants

D. Kumar¹, M. Demehin¹, J. Christensen¹, L. Kamal¹, I. Moinuddin¹, M. Levy¹, C. Bhati¹, A. King¹, H. D. Massey¹, P. Halloran², G. Gupta¹

Biomarkers, Immune Assessment and Clinical Outcomes V • Virtual

4:27pm-4:39pm: Therapeutic Targeting of Bile Acid Metabolism Ameliorates Liver Ischemia/Reperfusion Injury

M. Ni¹, D. Jin², T. Lu², J. Zhang¹, R. Busuttil¹, J. Kupiec-Weglinski¹, J. Zhang², Y. Zhai¹

All Organs: Organ Preservation/Ischemia Reperfusion Injury • Virtual

4:27pm-4:39pm: Timing of Bariatric Surgery for Obese Kidney Transplant Candidates

R. A. Choudhury¹, D. Yoeli¹, G. Hoeltzel², H. B. Moore¹, H. Yaffe¹, K. R. Dumon³, N. N. Williams³, P. L. Abt⁴, K. D. Conzen¹, T. Pshak¹, P. T. Kennealey¹, T. L. Nydam¹

Kidney: Cardiovascular and Metabolic Complications I • Virtual

4:27pm-4:39pm: Transplant Surgery Continuing Professional Development Courses Increase Knowledge and Procedural Confidence

M. J. Hobeika¹, T. Menser², A. Kassam³, T. C. Rice⁴, T. S. Diwan³

Surgical Issues • Virtual

4:27pm-4:39pm: Type 1 Innate Lymphoid Cells Are Critical Pro-Inflammatory Effector Cells in a Fatty Liver Mouse Model of Ischemia-Reperfusion Injury

J. Kang, K. Loh, J. Green, M. Sadat, M. Stovroff, A. Duttargi, B. Kallakury, K. Khan, T. Fishbein, A. Kroemer

Innate Immunity; Chemokines, Cytokines, Complement • Virtual